AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-2691753_ITM" title="Facts and information about New Depakote warning. (FYI).">New Depakote warning. (FYI).</a>
Close
Set up an RSS feed that alerts you when new articles from OB GYN News are available.
Frequently asked questions about RSS feeds
New Depakote warning. (FYI).
The Food and Drug Administration and Abbott Laboratories have strengthened the contraindications, warnings, and precautions sections of the label for divalproex sodium, valproic acid, and valproate sodium, marketed as Depakote tablets, Depakote ER tablets, Depakote sprinkle capsules, Depakene capsules and syrup, and Depacon for injection. Depakote ER is indicated for prophylaxis of migraine in adults. Letters were sent to ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- FDA approval granted for once-daily Depakote ER.
- Newspaper article from: Biotech Week January 22, 2003 700+ words
...Administration (FDA) has approved Depakote ER (divalproex sodium extended-release...absence seizures in adults with epilepsy. Depakote ER is the once-daily formulation of Depakote...epilepsy since its approval in 1983. Depakote ER was approved for migraine prevention...
- Divalproex ER approved for pediatric use.(News Notes)(Depakote ER from Abbott...
- Newspaper article from: The Brown University Child and Adolescent Psychopharmacology Update October 1, 2003 700+ words
...approved divalproex extended-release (Depakote ER) tablets for sole and adjunctive therapy...Depakote delayed-release tablets or Depakote ER tablets. All subjects were given doses of Depakote ER equivalent to their previous doses and...
- Abbott Laboratories' once-daily Depakote ER (divalproex sodium extended-...
- News wire article from: Asia Africa Intelligence Wire September 9, 2003 700+ words
...Administration (FDA) has approved Depakote ER (divalproex sodium extended release...epilepsy. In a pharmacokinetic study of Depakote ER in paediatric patients, the clinical researchers found that Depakote ER produces consistent, therapeutic...
- Divalproex sodium, valproic acid, Valproate (common name for both forms)...
- Newspaper article from: The Brown University Geriatric Psychopharmacology Update April 1, 2006 700+ words
...mania associated with bipolar disorder. DEPAKOTE ER (extended release) is indicated for...without psychotic features. DEPAKOTE and DEPAKOTE ER are indicated for treating complex partial...weeks. The most common side effects of DEPAKOTE ER are drowsiness, dyspepsia, nausea...
- Abbott Laboratories receives FDA approval for once-Daily Depakote ER...
- News wire article from: Asia Africa Intelligence Wire December 20, 2002 700+ words
...Administration (FDA) has approved Depakote ER (divalproex sodium extended-release...absence seizures in adults with epilepsy. Depakote ER is the once-daily formulation of Depakote...epilepsy since its approval in 1983. Depakote ER was approved for migraine prevention...
- Abbott's Depakote ER (divalproex sodium extended-release tablets) approved for...
- News wire article from: Chemical Business Newsbase December 7, 2005 700+ words
...has approved a new indication for Depakote ER (divalproex sodium extended-release...with or without psychotic features. Depakote ER offers patients the convenience of taking...once a day. Compared with Depakote, Depakote ER taken once a day helps provide more...
- Divalproex sodium, valproic acid (generic) ~ Depakote, Depakote ER, Depakene...
- Newspaper article from: The Brown University Child and Adolescent Psychopharmacology Update Leonard, Henrietta L. December 1, 2003 700+ words
...dosage is 60 mg/kg/day. The extended release formulation (Depakote ER) should be taken once daily, with a starting dose of 500...125 mg to 500 mg. Depakene is also available as a syrup. Depakote ER comes in 250 mg and 500 mg tablets. Storage: Store this...
- IMPAX Announces Lawsuit Related to Generic Version of Depakote ER.
- Press release article from: Business Wire June 19, 2007 700+ words
...or that the listed patents are invalid. Abbott markets Depakote ER for the treatment of epilepsy and bipolar disorders. According to Wolters Kluwer Health, U.S. sales of Depakote ER tablets were approximately $697 million in the 12 months...
- Depakote ER approved for certain forms of epilepsy. (News...
- Magazine article from: Brown University Psychopharmacology Update February 1, 2003 700+ words
...announced it had received approval from the Food and Drug Administration (FDA) for divaiproex extended-release tablets (Depakote ER) for the sole and adjunctive treatment of complex partial seizures and simple and complex absence seizures in adults with...
- FDA expands indiction of Abbott's Depakote ER.(Food and Drug...
- Newspaper article from: Pharma Marketletter December 12, 2005 700+ words
The US Food and Drug Administration has approved a new indication for US health care major Abbott Laboratories' Depakote ER (divalproex sodium extended-release tablets) for the treatment of acute manic or mixed episodes associated with bipolar...
Source: HighBeam Research, New Depakote warning. (FYI).